Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
EB
ELDON BIOLOGICALS A/S
aktivCVR 26747007AktieselskabSandtoften 10, 2820 GentofteFremstilling af andre kemiske produkter i.a.n.
- Latest accounts
- 2026
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2026
Revenue
Not available from the published filing—
Not available from the published filing
Operating profit
DKK 3.8m
Latest period
Source details
Source: dk-regnskabsdata-live-26747007-1793894099981
Document: dk-regnskabsdata-26747007-AaF9qmIZntWaBrQWtELF-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ctx1
Unit: vDKK
Net result
DKK 2.6m
Latest period
Source details
Source: dk-regnskabsdata-live-26747007-1793894099981
Document: dk-regnskabsdata-26747007-AaF9qmIZntWaBrQWtELF-1
XBRL: fsa:ProfitLoss
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ctx1
Unit: vDKK
Equity
DKK 42.6m
Equity ratio: 86.8%
Source details
Source: dk-regnskabsdata-live-26747007-1793894099981
Document: dk-regnskabsdata-26747007-AaF9qmIZntWaBrQWtELF-1
XBRL: fsa:Equity
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: ctx7
Unit: vDKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2023 | — | DKK 5.4m |
| 2024 | — | DKK 6.7m |
| 2025 | — | DKK 3.9m |
| 2026 | — | DKK 2.6m |